CRBU - Caribou Biosciences to Participate in Upcoming Investor Conferences | Benzinga

BERKELEY, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company's participation in the following investor conferences:

• Citi 18^th Annual BioPharma Conference, Boston, MA
  September 6, 2023
• Wells Fargo Healthcare Conference, Boston, MA
  September 7, 2023, 8:00 am EDT
• Morgan Stanley 21^st Annual Global Healthcare Conference, New York, NY
  September 11, 2023
• Jefferies Cell & Genetic Medicine Summit, New York, NY
  September 26-27, 2023

For more information and links to available webcasts, visit the Events page on Caribou's website. Webcasts will be ...

Full story available on Benzinga.com